Hogan Lovells has advised Definium Therapeutics, Inc. Definium Therapeutics, Inc. (Nasdaq: DFTX), a late-stage clinical biopharmaceutical company formerly known as Mind Medicine, has completed an upsized...
Definium Therapeutics Completes $805 Million Upsized Public Offering
MindMed Completes US$259 Million Public Offering
Hogan Lovells has advised Mind Medicine (MindMed) Inc. Mind Medicine (MindMed) Inc., a late-stage clinical biopharmaceutical company focused on developing product candidates for brain health disorders,...
Mind Medicine Inc’s $75 Million Common Shares Offering
Hogan Lovells advised Mind Medicine Inc. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), completed its underwritten public offering of 9,285,511 common shares, without value, at an offering...


























